
TSLA
- Market cap
- $786B
- Sector
- Consumer discretionary

Based on 37 analysts for FY2026
Dollars per share. The record, then the analysts' mean; the dashed lines are their lowest and highest estimate; Oryn's base case is the accent line.
Illustrative estimates; Oryn's line is the base case its DCF run of 8 Sep 2026 stored
Solid, filled: reported, then the consensus meanDashed: the lowest and highest estimateAccent: Oryn's base case, as its DCF run stored it
Oryn's base case against the consensus mean, earnings per share
Each year on one scale, as a difference from that year's consensus mean (the ink line, 0%). The accent mark is Oryn's base case; the grey band is its bear-to-bull range.
Illustrative estimates and paths
Oryn's bear, base and bull are the cases its DCF run of 8 Sep 2026 stored (run run-tsla), year by year. A "Consensus" year is one the run took from the analysts' panel; a "Fade" year is the run's own past it.
Oryn's EPS is each case's net income over the run's 3.21B shares outstanding, counted on 8 Sep 2026; the analysts' EPS is diluted, so at equal earnings Oryn's reads a little higher.
Where this page's consensus covers the year, Oryn's base case is up to +5.5% from its mean: the run read the consensus as of its own date and divides by its own share count.
FY2029–FY2030: the run's fade past the analysts' panel, growth narrowing toward its terminal rate with the margin held.
| Fiscal year | Reported | Consensus low | Consensus mean | Consensus high | Analysts | Oryn bear | Oryn base | Oryn bull | Base vs consensus | Oryn year from |
|---|---|---|---|---|---|---|---|---|---|---|
| FY2021 | $1.40 | — | — | — | — | — | — | — | — | — |
| FY2022 | $2.55 | — | — | — | — | — | — | — | — | — |
| FY2023 | $3.23 | — | — | — | — | — | — | — | — | — |
| FY2024 | $3.12 | — | — | — | — | — | — | — | — | — |
| FY2025 | $2.77 | — | — | — | — | — | — | — | — | — |
| FY2026 | — | $2.23 | $2.38 | $2.58 | 37 | $2.25 | $2.40 | $2.61 | +0.8% | Consensus |
| FY2027 | — | $2.36 | $2.63 | $2.98 | 31 | $2.38 | $2.74 | $3.01 | +4.2% | Consensus |
| FY2028 | — | $2.49 | $2.90 | $3.40 | 25 | $2.51 | $3.06 | $3.43 | +5.5% | Consensus |
| FY2029 | — | — | — | — | — | $2.59 | $3.20 | $3.62 | — | Fade |
| FY2030 | — | — | — | — | — | $2.65 | $3.28 | $3.71 | — | Fade |
Q3 FY2026, from 34 analysts
Moved in ninety days
4 quarters and 3 fiscal years
| Period | Revenue | Earnings per share | Analysts | Revision, 90 days |
|---|---|---|---|---|
| Quarters | ||||
| Q3 FY2026 | $26.83B | $0.63 | 34 | −0.5% |
| Q4 FY2026 | $28.43B | $0.66 | 32 | +0.9% |
| Q1 FY2027 | $26.41B | $0.63 | 30 | +0.4% |
| Q2 FY2027 | $27.24B | $0.65 | 28 | +2.2% |
| Fiscal years | ||||
| FY2026 | $104.34B | $2.38 | 37 | +0.1% |
| FY2027 | $110.60B | $2.63 | 31 | −0.4% |
| FY2028 | $117.01B | $2.90 | 25 | +1.3% |
| Period | Revenue | Estimate | Surprise | Earnings per share | Estimate | Surprise | Analysts |
|---|---|---|---|---|---|---|---|
| Quarters | |||||||
| Q2 FY2026 | $24.92B | $24.81B | +0.4% | $0.55 | $0.53 | +3.8% | 29 |
| Q1 FY2026 | $24.16B | $24.33B | −0.7% | $0.54 | $0.54 | +0.0% | 34 |
| Q4 FY2025 | $26.82B | $26.71B | +0.4% | $0.60 | $0.57 | +5.3% | 29 |
| Q3 FY2025 | $25.30B | $25.50B | −0.8% | $0.56 | $0.53 | +5.7% | 33 |
| Fiscal years | |||||||
| FY2025 | $99.40B | $100.57B | −1.2% | $2.77 | $2.65 | +4.5% | 40 |
| FY2024 | $97.70B | $96.84B | +0.9% | $3.12 | $3.01 | +3.7% | 39 |
Target range vs price
The grey band spans the lowest and highest published target; the marked figure is the mean of 18 targets and the vertical line is today’s price.
Published targets collected to 8 Sep 2026 · third-party; not an Oryn output